Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
doi: 10.1016/s0278-5846(96)00103-0
[11] GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications primarily licensed in the UK for the treatment of type 2 diabetes and, more recently, for weight management in specific patient groups
The most common options include semaglutide and tirzepatide
We tailor these advanced GLP-1 receptor agonist therapies, including Ozempic, to each patient, ensuring individualized care that effectively supports diabetes management and cardiovascular risk reduction
US$ 27.33
US$ 23.74
US$ 28.66
US$ 23.74
US$ 25.83
US$ 25.72
